Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 16, Issue 1, 2014, Pages 90-93

  Mayer, S B ^a   Jeffreys, A S ^b   Olsen, M K ^a,b   Mcduffie, J R ^b   Feinglos, M N ^a   Yancy, W S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Glycaemic control; Low carbohydrate diet; Low fat diet; Medication therapy management; Orlistat

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE DIET; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG POTENCY; FEMALE; GLUCOSE METABOLISM; HUMAN; LOW CARBOHYDRATE DIET; LOW FAT DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

GLYCAEMIC CONTROL; LOW-CARBOHYDRATE DIET; LOW-FAT DIET; MEDICATION THERAPY MANAGEMENT; ORLISTAT;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; DIET, REDUCING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84890555093     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12191     Document Type: Article

References (11)

1. Wheeler ML, Dunbar SA, Jaacks LM et al. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010. Diabetes Care 2012; 35: 434-445.
2. Nathan DM, Buse JB, Davidson MB et al. American Diabetes A and European Association for Study of D: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203.
3. Yancy WS Jr, Westman EC, McDuffie JR et al. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch Intern Med 2010; 170: 136-145.
4. Cochran E, Musso C, Gorden P. The use of U-500 in patients with extreme insulin resistance. Diabetes Care 2005; 28: 1240-1244.
5. Jacob S, Rabbia M, Meier MK, Hauptman J. Orlistat 120mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes Obes Metab 2009; 11: 361-371.
6. Kirk JK, Graves DE, Craven TE, Lipkin EW, Austin M, Margolis KL. Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. J Am Diet Assoc 2008; 108: 91-100.
7. Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab 2010; 12: 204-209.
8. Allick G, Bisschop PH, Ackermans MT et al. A low-carbohydrate/high-fat diet improves glucoregulation in type 2 diabetes mellitus by reducing postabsorptive glycogenolysis. J Clin Endocrinol Metab 2004; 89: 6193-6197.
9. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005; 142: 403-411.
10. Dorman RB, Serrot FJ, Miller CJ et al. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg 2012; 255: 287-293.
11. Stevens LA, Nolin TD, Richardson MM et al; Chronic Kidney Disease Epidemiology Collaboration. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009; 54: 33-42.